2019, Number 1
<< Back
Rev Clin Esc Med 2019; 9 (1)
Generalidades de Enfermedad Celiaca y abordaje diagnóstico
Murillo SJA, Piedra CW, Sequeira CD, Sánchez MES, Sandoval LD
Language: Spanish
References: 12
Page: 64-69
PDF size: 170.64 Kb.
ABSTRACT
The celiac disease (CD) is a permanent Gluten
intolerance, with a prevalence of 1%, which
increases in people with autoimmune diseases,
chromosomopathies, or first degree relatives
with CD. Clinically it can be asymptomatic,
or produce a florid malabsorption syndrome,
with gastrointestinal and extra gastrointestinal
symptoms, with impaired nutritional status. The
diagnosis is made based on clinical suspicion,
serological tests, genetic studies (HLA DQ2 / 8),
and the duodenal biopsy, that is the gold standard
for diagnosis. The treatment is maintaining a
gluten-free diet for life.
REFERENCES
Grupo de trabajo del Protocolo para el diagnóstico precoz de la enfermedad celíaca. Protocolo para el diagnóstico precoz de la enfermedad celíaca. Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Evaluación del Servicio Canario de la Salud (SESCS). España, 2018. http://portal.guiasalud. es/contenidos/iframes/documentos/opbe/2018- 05/SESCS_2018_Protocolo_diag_precoz_EC.pdf Ministerio de Sanidad y Consumo España Diagnóstico precoz de la enfermedad celíaca Madrid
Vaquero L Rodriguez L León F Jorquera F Vivas S. New coeliac disease treatments and their complications. Gastroenterol Hepatol. 2018;41(3):191-204. https://www.sciencedirect.com/ science/article/pii/S2444382418300415?via%3Dihub
Rubio A Hill I Ciarán K Calderwood A Murray J. Diagnosis and Management of Celiac Disease. Am J Gastroenterol. 2013; 108:656–676; doi:10.1038/ ajg.2013.79.https://gi.org/guideline/diagnosis-andmanagement- of-celiac-disease/
Kasper D Fauci A Hauser S Longo D Jameson J Loscalzo J. Harrison’s Principles of Internal Medicine. McGraw Hill Companies, Inc. New Cork – U.S.A. 19th Edition, 2016: 1940-1942.
Ciarán P Bai J Liu E Leffler D. Advances in Diagnosis and Management of Celiac Disease. Gastroenterology 2015;148:1175–1186. https://www. gastrojournal.org/article/S0016-5085(15)00162-6/fu lltext?referrer=https%3A%2F%2Fwww.ncbi.nlm.nih. gov%2F
Society for the Study of Celiac Disease (SSCD). CELIAC DISEASE DIAGNOSIS IN ADULTS. SSCD. Woodcreek- U.S.A. https://www.theceliacsociety. org/cd-adult_diagnosis_guide (Revisado 25 diciembre de 2018)
Werkstetter K Korponay-Szabó R Popp A et al. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice. Gastroenterology. 2017;153:924–935. https://www.ncbi.nlm.nih.gov/ pubmed/28624578
Wolf J Petroff D Richter T et al. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy. Gastroenterology 2017;153:410–419. https://www.ncbi.nlm.nih.gov/ pubmed/28461188
Fernández-Bañares F Esteve-Comas M Rosinach M. Cribado de la enfermedad celíaca en grupos de riesgo. Gastroenterol Hepatol. 2005;28(9):561-566
Olivencia P Cano R Martín S León P Roy A Redondo V .Enfermedad celíaca del adulto y linfocitos intraepiteliales. ¿Nuevas opciones para el diagnóstico?. Gastroenterol Hepatol. 2008;31(9):555- 559.
Fernándeza M Vivasa S Ruiz de Morales J Marugán J. Utilidad de los anticuerpos antitransglutaminasa en el diagnóstico de la enfermedad celíaca. Gastroenterol Hepatol. 2005;28(8):437-440.
Sarna V Lundin K Mørkrid L Qiao S Sollid L Christophersen A. HLA-DQ–Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption. Gastroenterology 2018;154:886–896. https://www. gastrojournal.org/article/S0016-5085(17)36352-7/ fulltext